What is Tesamorelin?
Tesamorelin is a synthetic analog of growth hormone-releasing hormone. It is distinguished from other secretagogues by a comparatively developed clinical literature, particularly regarding visceral adipose tissue.
Healthy Aging & Longevity
Tesamorelin
A stabilized GHRH analog with the most substantial clinical research base of the growth hormone secretagogues.
- Format
- 10mg vial — 2mg/mL, 5mL injectable
- Price
- $220 per vial
- Route
- Injectable
- Evidence level
- Established
- Regulatory status
- Off-Label
- Testing
- Baseline Labs Generally Required
Pricing reflects the compounded preparation and doctor review. Final therapy and dosing are determined only after your intake is reviewed.
Overview
Understanding Tesamorelin
Format & administration
Once-daily subcutaneous injection, usually at night. Protocols are typically longer-running with periodic lab reassessment.
Testing posture
Your doctor determines the final testing requirements for Tesamorelin after reviewing your intake. The panels below are what is commonly reviewed for this therapy — they are educational guidance, not a fixed requirement.
How it works
How Tesamorelin works
- 01Tesamorelin binds pituitary GHRH receptors to stimulate endogenous growth hormone secretion, which in turn raises IGF-1.
- 02Research has focused notably on its effect on visceral rather than subcutaneous fat.
Show illustration: Tesamorelin
What has been studied
Potential applications and evidence
These areas are commonly discussed within wellness-focused protocols. They are educational statements, not medical claims or guarantees of outcome.
Explored for visceral adipose tissue reduction
Discussed within metabolic health protocols
Potential support for body composition
Commonly tracked with IGF-1 and metabolic panels
Doctor-guided
A personalized approach
Your doctor determines the final testing requirements for Tesamorelin after reviewing your intake. The panels below are what is commonly reviewed for this therapy — they are educational guidance, not a fixed requirement.
Bloodwork status: Baseline Labs Generally Required
Commonly reviewed at baseline
- IGF-1
- Comprehensive metabolic panel (CMP)
- Fasting glucose and A1c
- Lipid panel
- Thyroid panel (TSH, free T4)
Follow-up & monitoring
IGF-1 and glycemic markers are typically reassessed at 8 to 12 weeks, then periodically while therapy continues.
Medication review
Your doctor reviews all prescriptions, supplements, and over-the-counter medications during intake before anything is prescribed.
Format & dosing
Once-daily subcutaneous injection, usually at night. Protocols are typically longer-running with periodic lab reassessment.
Safety
What patients should know
- Compounded preparations are not FDA-approved products. Not appropriate with active malignancy. Glucose tolerance should be monitored in at-risk patients.
Who may not be a candidate
- Pregnancy or nursing
- Active malignancy without oncology clearance
- Known hypersensitivity to the preparation
- Active pituitary disease
- Uncontrolled diabetes
Regulatory status: Off-Label. Evidence level: Established. Eligibility, dosing, laboratory requirements, and follow-up care are determined exclusively by a licensed doctor after review of your history.
Common questions
Frequently asked questions
Keep exploring
Related therapies
Healthy Aging & Longevity
CJC-1295 / Ipamorelin
Growth hormone optimization for body composition and recovery.
Baseline Labs Generally Required
$250View
Healthy Aging & Longevity
Tesamorelin / Ipamorelin
Dual GH secretagogue stack for fat loss and body composition.
Baseline Labs Generally Required
$250View
Healthy Aging & Longevity
MOTS-C
Mitochondrial-derived peptide for metabolic health and endurance.
Recent Labs Recommended
$160View
Ready when you are
Find out what your body is actually asking for.
Fill out a short intake form and our care team will build a plan grounded in your labs — not a guess from a supplement aisle.